Peptides Surge in Popularity Amid Regulatory Uncertainty
The use of peptides, short chains of amino acids, is gaining traction in the U.S. as individuals seek them for various health benefits, despite the lack of FDA approval. These substances are being marketed for purposes ranging from injury recovery to anti-aging, attracting biohackers, athletes, and even public figures like podcasters Joe Rogan and Andrew Huberman. While peptides have legitimate medical applications, such as in insulin and GLP-1 drugs, their broader use is largely unregulated, creating a gray market. This surge in popularity highlights a growing trend where consumers are willing to invest significant amounts of money, sometimes up to five figures annually, for these unapproved treatments. 
